A Timeline of Discovery
From cancer and flu to rare diseases, mRNA research is opening new possibilities for patients. Today’s breakthroughs are rooted in more than 60 years of scientific research and discovery. Explore the timeline to learn about the long history of mRNA research and the many important milestones along the way.
The moment scientists understood how every living cell carries its own instructions for building the proteins that keep us healthy, the foundation of all modern biology.
An early discovery that our cells naturally recognize and respond to mRNA, an insight scientists would later use to design medicines that work in harmony with the body.
Scientists learned that cells naturally fine-tune their own mRNA with small chemical tags, revealing a built-in system for tuning how mRNA behaves.
Researchers identified the natural protective “cap” that every healthy mRNA carries, the feature that keeps it stable and tells the cell to put it to work.
Made it possible to produce mRNA in the lab that mirrors our own body, enabling researchers to design precise, custom instructions.
An early version of the gentle protective coating that carries mRNA safely into cells, solving how to deliver a naturally fragile molecule intact.
When delivered into the body, mRNA successfully directed cells to produce a working protein – the first proof that this approach could help the body make its own medicine.
Demonstrated that mRNA could help the immune system recognize threats, an early step toward fighting cancer and infectious disease.
mRNA was shown to help the body build protective antibodies, the same natural defense that vaccines have safely harnessed for generations.
A refinement that ensures each mRNA is built correctly, so it works more efficiently and reliably.
Marked the first human study of an mRNA-based therapy, an early milestone in exploring how it could help patients fight cancer.
Scientists mapped exactly how cells sense mRNA, knowledge that let them design medicines that are gentle and well tolerated.
A landmark advance that let mRNA work smoothly and safely within the body, the breakthrough that made today’s well-tolerated mRNA medicines possible.
A refinement that helped mRNA last longer and produce more protein, turning a promising idea into a practical medicine.
The first human trial testing mRNA as a cancer treatment, extending the technology from prevention to therapy.
A version of mRNA that amplifies its own signal inside the cell, allowing a smaller dose to do more.
A manufacturing advance that made mRNA cleaner, more effective, and better tolerated, the refined approach that helped power the COVID-19 vaccines.
The first attempt to tailor a cancer vaccine to an individual patient’s own tumor, a preview of truly personalized medicine.
Another natural chemical tag was uncovered, expanding scientists’ understanding of how cells manage their own mRNA.
Six decades of careful, incremental science delivered a vaccine that helped protect millions of people worldwide.
Billions of COVID-19 vaccines would be administered worldwide within approximately two years, the most successful vaccine rollout in history
Researchers began designing mRNA to teach the immune system to recognize a patient’s own tumor, opening a path from prevention to treatment.
Scientists showed mRNA vaccines could be engineered to stay potent for months without deep-freezing, a practical breakthrough that makes the technology usable in clinics and countries without specialized cold storage.
Nobel Prize for the nucleoside-modification discovery that made mRNA medicines possible, cementing decades of patient research as one of the defining advances of modern medicine
The first approved medicine that uses RNA to guide a precise genetic correction, proving that RNA-directed editing can move from the lab to an approved treatment.
A tailor-made mRNA vaccine prompted lasting immune responses in one of the hardest cancers to treat, an early sign that individualized mRNA therapy could work where few options exist.
A personalized mRNA vaccine combined with existing immunotherapy meaningfully lowered the chance of cancer returning, the strongest clinical signal yet for mRNA as a cancer treatment.
The first approval of an mRNA that copies itself inside the body, allowing a much smaller dose to produce durable protection, a design that eases manufacturing and stretches limited supply.
mRNA’s approval against RSV proved the platform is a durable technology that can help protect patients against many diseases.
New delivery particles let scientists steer mRNA to tissues beyond the liver, expanding the range of diseases the technology can reach.
An engineered ring-shaped RNA, built to last far longer inside cells than ordinary mRNA, entered human testing, pointing toward treatments that could work from a single, longer-lasting dose.
Doctors designed and delivered a one-of-a-kind mRNA-based treatment for a baby’s unique genetic mutation within months of diagnosis, showing that mRNA can carry precise genetic corrections tailored to a single patient.
Researchers showed that mRNA delivered directly into the body can reprogram a patient’s own immune cells to fight cancer, an approach that could make today’s complex, costly cell therapies far simpler to give.
A naturally occurring chemical tag that can replace the current industry-standard building block in synthetic mRNA, producing more accurate protein output and pointing toward safer, more precise mRNA medicines.
If finalized, the framework would provide a clear, faster pathway for these bespoke treatments, turning a remarkable one-time effort into a repeatable route to help patients with ultra-rare diseases.
Partnerships advanced mRNA treatments that supply missing proteins for inherited metabolic disorders, extending the technology from vaccines toward lifelong therapies for rare conditions.
